Banyai William's Form 4 filing
Twist Bioscience Corp (TWST) · filed Jan 5, 2022
- Accession no.
- 0001214659-22-000329
- Filed
- Jan 5, 2022
- Trade date
- Jan 3-4, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $24.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Banyai WilliamCIK 0001753670 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2022 | Common Stock | FTax withholdingDisposed | −195 | $77.39 | −$15,091.05 | 266,290 | Direct | |
| Jan 4, 2022 | Common Stock | SSaleDisposed | −292 | $83.49 | −$24,379.08 | 265,998 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Senior Vice President of Advanced Development and General Manager of Data Storage